Clinical trial
Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography
NCT00335101 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography
- Lead sponsor
- GE Healthcare
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- June 30, 2006
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease (cad), diabetes mellitus, renal impairment